SCHEMBL7962802

SCHEMBL7962802

CCCOc1ccc(Cl)cc1C(=N)N

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 2/20 0.46
HTR2B P41595 2/20 0.46
CSNK2A1 P68400 2/20 0.45
MAPT P10636 3/20 0.45
PKM P14618 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
KDM4E B2RXH2 3/20 0.43
CCR5 P51681 3/20 0.43
NPC1 O15118 1/20 0.43
LMNA P02545 1/20 0.43
HPGD P15428 1/20 0.43
RAB9A P51151 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
BACE1 P56817 1/20 0.43
PTGER1 P34995 1/20 0.43
HSD17B10 Q99714 1/20 0.42
HIF1A Q16665 1/20 0.42
GAA P10253 2/20 0.41
KMT2A Q03164 2/20 0.41
MEN1 O00255 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17040591 0.87 TSHR (0.49) HTR2CHTR2BMAPTCCR5LMNA
Hydrochloric Acid SCHEMBL11629080 0.86 TSHR (0.48) HTR2CHTR2BMAPTCCR5LMNA
SCHEMBL7951291 0.84 HTR2B (0.50) HTR2CHTR2BCSNK2A1MAPTKDM4E
SCHEMBL2562274 0.83 PRSS1 (0.57) PRSS1
SCHEMBL2567834 0.83 KDM4E (0.44) CSNK2A1MAPTKDM4ENPC1LMNA
SCHEMBL16959814 0.82 L3MBTL1 (0.48) HTR2CHTR2BCSNK2A1MAPTPKM
SCHEMBL7961007 0.81 HTR2B (0.46) HTR2CHTR2BCSNK2A1MAPTKDM4E
SCHEMBL2568322 0.81 SMN1; SMN2 (0.59) MAPTKDM4ECCR5NPC1LMNA
SCHEMBL7962020 0.80 PRSS1 (0.47) MAPTKDM4ENPC1LMNAHPGD
SCHEMBL20522075 0.79 GAA (0.61) MAPTPKML3MBTL1LMNAPTGER1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6200980-B1 ADMINISTERING PHENYL PURINONE COMPOUND FOR TREATING PRECANCEROUS LEISONS CELL PATHWAYS, INC. 2001-03-13 US disclosed
EP-0352960-B1 Purine compounds, process for their preparation and pharmaceutical compositions SMITH KLINE FRENCH LAB (GB) 1994-10-26 EP disclosed
US-5073559-A 2-Substituted purinone having phosphodiesterase inhibitory activity SMITH KLINE & FRENCH LABORATORIES, LTD. (GB) 1991-12-17 US disclosed
EP-0352960-A2 Purine compounds, process for their preparation and pharmaceutical compositions SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1990-01-31 EP disclosed